Today’s guest is Brandon Rice, Chief Product Officer at Weave. Founded in 2023, Weave Bio is an AI-native regulatory automation management platform redefining regulatory submissions for novel therapeutic candidates. Designed for pharma, biotech, CROs and consultants, the Weave Platform streamlines regulatory document preparation and lifecycle management by automating initial draft documents, extracting key insights and integrating study data into a seamless, AI-enabled workflow.
The platform accelerates regulatory processes, enabling faster drafting, high-quality reviews and compliance with global standards. AutoIND, widely adopted for preclinical IND submissions, earned the “Biotech AI Innovation of the Year” award. With AutoCT, Weave expanded capabilities into clinical-stage submissions, building the foundation for a singular AI workbench for the entire therapy lifecycle.